Search PubMed⌕ Search

Biomedical subjects

D Kuhn

Publications and source records attributed to D Kuhn.

At least 55 records · Page 3Linked to original sources

Carboxylmethylation of phosphodiesterase attenuates its activation by ca2+-calmodulin.

Carboxylmethylation of several preparations of cAMP phosphodiesterase by the enzyme protein O- carboxylmethyltransferase and S-adenosylmethionine reduces the extent to which the enzyme was activated by native calmodulin. In contrast, carboxylmethylation of calmodulin produced only a slight reduction in the ability of calmodulin to activate cAMP phosphodiesterase. The effect of carboxylmethylation of calmodulin was most prominent at subsaturating calmodulin concentrations, whereas the reduction in the activation of carboxylmethylated cAMP phosphodiesterase was independent of calmodulin concentration. Kinetics and stoichiometric analysis of calmodulin carboxylmethylation indicated that less than 5% of calmodulin was methylated and that the Km of protein O- carboxylmethyltransferase for calmodulin was approximately 350 microM. The extent of calmodulin carboxylmethylation was not affected by either EGTA or Ca2+. When homogeneous bovine brain phosphodiesterase was carboxylmethylated , a rapid decrease in calmodulin-induced stimulation was noted, occurring within 30 s of incubation. Acidic sodium dodecyl sulfate-gel electrophoresis of bovine brain phosphodiesterase revealed a major band of 60,000 daltons which contained radio-activity after carboxylmethylation . Stoichiometric analysis revealed that approximately 20% of the phosphodiesterase was carboxylmethylated . Thus, although calmodulin can serve as a substrate for carboxylmethylation , it appears that carboxylmethylation has a greater effect on calmodulin-dependent phosphodiesterase activity when the target enzyme, rather than calmodulin, is carboxylmethylated .

3',5'-Cyclic-AMP Phosphodiesterases↗

Identification of the chloramphenicol-hydrolyzing enzyme of guinea pig liver as one of the nonspecific carboxylesterases.

Guinea pig liver has the highest chloramphenicol-hydrolyzing capacity among the livers of various mammals. The enzyme responsible for the hydrolysis of the amide-bond in chloramphenicol is one of the isoenzymes of the microsomal nonspecific carboxylesterases. This isoenzyme is related to the well-known acetanilide-hydrolyzing carboxylesterases/amidases of pig and rat liver. The guinea pig liver enzyme is purified 24-fold starting with microsomes. The purified enzyme is essentially free from other proteins except other carboxylesterase isoenzymes with similar properties. The chloramphenicol-hydrolyzing esterase has an apparent molecular weight of about 180,000, a subunit weight of 60,000 and a pH optimum at 8.5. It also hydrolyzes methyl butyrate and acetanilide and it is completely inhibited by diethyl-4-nitrophenyl phosphate. Two assay procedures for the enzymatic chloramphenicol hydrolysis are described: a thin-layer chromatographic assay using radioactive chloramphenicol and a colorimetric assay utilizing the reaction of the liberated amine with trinitrobenzenesulfonic acid.

Animals↗

Sex role concepts of two- and three-year-olds.

An instrument was developed to assess beliefs about males and females in very young children. Use of the instrument with 72 2- and 3-year-old subjects indicated that children as young as 2 years of age possess substantial knowledge of sex role stereotypes prevailing in the adult culture. Knowledge of sex role stereotypes was highly correlated (.85) with comprehension of gender identity as an irreversible characteristic. Subjects who indicated actual or ideal identity with the opposite sex, however, showed a level of stereotyping no greater than chance. While there were no differences in amount of stereotyping as a function of subjects' age or sex, an analysis of the content of subjects' stereotypes revealed that boys' and girls' beliefs were only partially overlapping. In particular, girls tended to ascribe positive characteristics to their own sex and negative characteristics to males, while boys did the reverse. Explanations for these findings in terms of self-valuation processes were suggested.

Affect↗

[Results of clinical trials with the cation exchange preparation campanyl in the therapy and metaphylaxis of calcium-containing urinary calculi (author's transl)].

The efficacy of the cation exchange preparation Campanyl (T1286) was tested in the treatment and metaphylaxis of calcium-containing urinary calculi. For this purpose, in vitro experiments, animal exeriments, orienting clinical studies in 79 patients, and a long term clinical trial in 42 patients over 12 months were undertaken; 22 of the latter patients are also still being treated with the cation exchange preparation, the observation period for 15 patients being 3 1/2 years and 2 1/2 years for 7 patients. As a result of these studies a lowering of the medium calcium excretion and a reduction of calculus discharge by more than half was achieved in the patients being treated with the cation exchanger, without restriction of calcium in the diet. There was not yet seen litholysis. Serious side effects or an influence on the serum electrolytes was not recorded with Campanyl (T1286).

Calcium↗

Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion.

Patients with storage pool disease and normal subjects who ingest aspirin show diminished collagen-induced platelet aggregation and an absent second wave of aggregation with ADP or adrenaline. These 'second-phase' aggregation responses are thought to be mediated by cyclic endoperoxide ('labile aggregation stimulating substance', LASS) that is derived from arachidonic acid and is the precursor of prostaglandin E2 (PGE2) and PGE2alpha. Furthermore, although PGE2 does not directly aggregate platelets, it markedly potentiates LASS-induced aggregation. The platelets of six patients with storage pool disease were capable of converting arachidonic acid to LASS, but the potentiation of LASS-induced aggregation by PGE2 was markedly diminished. In contrast, PGE2-potentiation of LASS aggregation was not reduced after aspirin ingestion. The effects of aspirin can be attributed entirely to its ability to block the enzymatic conversion of arachidonic acid to LASS and PGE2. These findings explain why a mutual correction of the aggregation defects is often seen when aspirin-treated platelets are mixed with storage pool-deficient platelets. This is because 'aspirin platelets' aggregate to the mixture of LASS and PGE2 produced by the storage pool-deficient platelets, which are themselves unresponsive. The findings in storage pool disease support previous conclusions that prostaglandin sensitization of platelets to the pro-aggregatory effects of LASS is an important factor in irreversible aggregation, and could be clinically important.

Adenosine Diphosphate↗